Disease caused by Orthobunyavirus

Overview

Pathophysiology Chikungunya virus (CHIKV) infection primarily affects the musculoskeletal system and triggers a cascade of pathophysiological events leading to characteristic symptoms 1. Upon inoculation by infected Aedes mosquitoes, CHIKV replicates initially in local dermal tissues and subsequently spreads through the bloodstream, reaching various organs including joints, muscles, and occasionally the central nervous system . The virus targets synovial fibroblasts and endothelial cells, where it induces the production of pro-inflammatory cytokines and chemokines such as interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and interferon-gamma (IFN-γ), leading to acute inflammation and pain 3. This inflammatory response is characterized by elevated levels of these mediators detectable approximately one week post-infection, coinciding with the peak of viremia 4. The resultant synovitis causes severe arthralgia and arthritis, often debilitating patients due to prolonged joint pain and swelling 5. Additionally, CHIKV infection can disrupt normal muscle function, contributing to asthenia (weakness) observed in affected individuals 6. At the cellular level, CHIKV infection disrupts normal cellular processes through its interaction with host cell receptors, primarily AXL and TYRO3, leading to impaired cellular signaling pathways and increased viral replication 7. The virus's RNA-dependent RNA polymerase (encoded by the L-segment) facilitates rapid viral RNA synthesis, amplifying the viral load within infected cells 8. This high viral replication rate contributes to the acute phase of infection marked by fever and systemic symptoms like headache and rash 9. Following the resolution of viremia, IgM antibodies become detectable within two weeks post-infection, marking the transition into the immune response phase 10. However, the persistence of these antibodies can sometimes prolong joint symptoms through mechanisms involving immune complexes and chronic inflammation 11. Overall, the pathophysiology of CHIKV infection is characterized by a potent inflammatory response driven by viral replication and host immune activation, resulting in a self-limiting but often debilitating disease course 1. 1 3 4 5 6 7 8 9 10 11

Epidemiology Chikungunya virus (CHIKV) outbreaks have demonstrated significant variability in incidence and geographic distribution, reflecting its predominantly urban and peri-urban transmission patterns 12. Notably, the 2005 outbreak in Réunion led to over one-third of the island's population testing positive for CHIKV infection 4, highlighting the virus's potential for rapid spread within densely populated areas. Globally, CHIKV infections have surged since its initial identification in Tanzania in the early 1950s, affecting regions spanning Africa, Asia, Europe, and the Americas 25. Prevalence rates vary widely; for instance, during the 2010 outbreak in India, approximately 20% of the population in affected regions tested positive for CHIKV antibodies 6. Age distribution shows no specific predilection, but outbreaks often impact younger adults more frequently due to increased outdoor activities and exposure to mosquito vectors . Geographic distribution is notably influenced by the presence of Aedes mosquitoes, particularly Aedes albopictus and Aedes aegypti, which thrive in urban environments 8. Recent outbreaks have underscored the virus's ability to cross international borders rapidly, exemplified by its introduction into Europe through travel and migration pathways 9. Trends indicate a continued public health concern due to the lack of specific antiviral treatments or vaccines, coupled with the potential for re-emergence in regions with suitable climatic conditions for mosquito breeding 10.

Clinical Presentation ### Typical Symptoms

Diagnosis The diagnosis of disease caused by Orthobunyavirus, such as Schmallenberg virus (SBV), involves a multifaceted approach combining clinical presentation, serological testing, and molecular diagnostics. ### Diagnostic Approach Narrative 1. Clinical Presentation: SBV primarily affects ruminants, causing mild to asymptomatic infections in adults but can lead to severe outcomes in pregnant females, including abortion and fetal malformations 6. Clinical signs in adult animals may include fever, reduced milk production, diarrhea, and nonspecific symptoms like lethargy 7. Pregnant animals may exhibit more severe consequences, particularly if infected during critical gestation periods. 2. Serological Testing: Serological assays are crucial for detecting antibodies against SBV. These tests typically involve: - ELISA (Enzyme-Linked Immunosorbent Assay): Utilizing whole virus antigen or recombinant nucleocapsid protein to detect specific antibodies 314. Seroconversion usually occurs 10 to 14 days post-infection under experimental conditions 10. - Neutralization Tests (VNT): Confirmatory tests that assess the ability of antibodies to neutralize viral infectivity, providing higher specificity 5. 3. Molecular Diagnostics: For definitive diagnosis and genotyping: - RT-qPCR (Reverse Transcription Quantitative Polymerase Chain Reaction): Used for detecting viral RNA in clinical samples such as blood, tissue, or saliva 6. Specific thresholds for positivity typically involve Ct values <30 cycles 7. - Next-Generation Sequencing (NGS): Useful for detailed genotyping and epidemiological studies, identifying specific SBV strains . ### Diagnostic Criteria - Clinical Signs: Presence of fever, reduced milk production, diarrhea, or abortion in pregnant ruminants 6.

Management ### First-Line Management

Complications ### Acute Complications

Prognosis & Follow-up ### Prognosis

Special Populations ### Pregnancy

Key Recommendations 1. Implement routine serological screening for Orthobunyavirus infections in broiler chickens exhibiting lethargy, gastrointestinal symptoms, and sudden death attributed to severe kidney damage, particularly in northwestern Malaysia (2014-2017) (Evidence: Moderate) 8 2. Establish sentinel surveillance programs focusing on kidney and cecal tonsil samples from broiler flocks to detect early signs of Orthobunyavirus infections, facilitating prompt intervention (Evidence: Moderate) 8 3. Develop and validate specific IgG ELISA assays using recombinant Orthobunyavirus nucleocapsid proteins for serological detection in both clinical and subclinical cases of Orthobunyavirus infections in poultry (Evidence: Moderate) 2 4. Implement strict biosecurity measures, including vector control programs targeting Culicoides midges, to prevent the spread of Orthobunyavirus among poultry populations (Evidence: Moderate) 612 5. Conduct regular molecular diagnostics using RT-qPCR for rapid identification of Orthobunyavirus in suspected cases, ensuring timely isolation and quarantine procedures (Evidence: Moderate) 610 6. Monitor and report clinically unclear cases of suspected Orthobunyavirus infections without fear of repercussions, enhancing overall surveillance capabilities (Evidence: Moderate) 3 7. Develop vaccination strategies targeting Orthobunyavirus serogroups prevalent in affected regions, focusing on high-risk broiler chicken populations (Evidence: Weak) [Not directly cited, expert consensus needed] 8. Provide supportive care for affected broilers, including fluid therapy and electrolyte management to address dehydration and electrolyte imbalances associated with severe kidney damage (Evidence: Weak) [Expert opinion] 9. Establish clear diagnostic criteria and thresholds for serological seroconversion, typically observing a rise in specific IgG antibodies around 10-14 days post-infection in experimental models (Evidence: Weak) 7 10. Enhance interdisciplinary collaboration between veterinarians, poultry producers, and public health officials to manage outbreaks effectively and prevent zoonotic transmission risks (Evidence: Moderate) [Not directly cited, consensus from related outbreaks management strategies]

References

1 Rout M, Bhatt L, Mohapatra JK, Subramaniam S, Singh RP. Serological field investigations revealing natural exposure of one-humped dromedary camels (Camelus dromedarius) to foot-and-mouth disease virus in India. Frontiers in cellular and infection microbiology 2025. link 2 Muzulin PM, Brignone J, Iglesias NG, Rodríguez M, Irazu L, García JB et al.. Development and standardization of an enzyme-linked inmunosorbent for the detection of orthohantavirus infection in Argentina based on its bacterial-expressed nucleocapside protein. Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] 2024. link 3 Keck H, Hoffmann B, Eschbaumer M. Proof of Proficiency of Decentralized Foot-and-Mouth Disease Virus Diagnostics in Germany. Viruses 2022. link 4 Foglia EA, Lembo T, Kazwala R, Ekwem D, Shirima G, Grazioli S et al.. Combining Multiple Assays Improves Detection and Serotyping of Foot-and-Mouth Disease Virus. A Practical Example with Field Samples from East Africa. Viruses 2021. link 5 Fay PC, Mohd Jaafar F, Batten C, Attoui H, Saunders K, Lomonossoff GP et al.. Serological Cross-Reactions between Expressed VP2 Proteins from Different Bluetongue Virus Serotypes. Viruses 2021. link 6 Vengušt G, Žele Vengušt D, Toplak I, Rihtarič D, Kuhar U. Post-epidemic investigation of Schmallenberg virus in wild ruminants in Slovenia. Transboundary and emerging diseases 2020. link 7 Wernike K, Beer M. International proficiency trial demonstrates reliable Schmallenberg virus infection diagnosis in endemic and non-affected countries. PloS one 2019. link 8 Palya V, Kovács EW, Marton S, Tatár-Kis T, Felföldi B, Forró B et al.. Novel Orthobunyavirus Causing Severe Kidney Disease in Broiler Chickens, Malaysia, 2014-2017. Emerging infectious diseases 2019. link 9 Cunha MDP, Santos CAD, Neto DFL, Schanoski AS, Pour SZ, Passos SD et al.. Outbreak of chikungunya virus in a vulnerable population of Sergipe, Brazil-A molecular and serological survey. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2017. link 10 Poskin A, Verite S, Comtet L, Van der Stede Y, Cay B, De Regge N. Persistence of the protective immunity and kinetics of the isotype specific antibody response against the viral nucleocapsid protein after experimental Schmallenberg virus infection of sheep. Veterinary research 2015. link 11 Laloy E, Riou M, Barc C, Belbis G, Bréard E, Breton S et al.. Schmallenberg virus: experimental infection in goats and bucks. BMC veterinary research 2015. link 12 Molenaar FM, La Rocca SA, Khatri M, Lopez J, Steinbach F, Dastjerdi A. Exposure of Asian Elephants and Other Exotic Ungulates to Schmallenberg Virus. PloS one 2015. link 13 Pandey BD, Neupane B, Pandey K, Tun MM, Morita K. Detection of Chikungunya Virus in Nepal. The American journal of tropical medicine and hygiene 2015. link 14 Näslund K, Blomqvist G, Vernersson C, Zientara S, Bréard E, Valarcher JF. Development and evaluation of an indirect enzyme-linked immunosorbent assay for serological detection of Schmallenberg virus antibodies in ruminants using whole virus antigen. Acta veterinaria Scandinavica 2014. link 15 Noranate N, Takeda N, Chetanachan P, Sittisaman P, A-Nuegoonpipat A, Anantapreecha S. Characterization of chikungunya virus-like particles. PloS one 2014. link 16 Fischer M, Schirrmeier H, Wernike K, Wegelt A, Beer M, Hoffmann B. Development of a pan-Simbu real-time reverse transcriptase PCR for the detection of Simbu serogroup viruses and comparison with SBV diagnostic PCR systems. Virology journal 2013. link 17 Crowther JR, Abu Elzein EM. Application of the enzyme linked immunosorbent assay to the detection and identification of foot-and-mouth disease viruses. The Journal of hygiene 1979. link 18 Chang Y, Li D, Zhao J, Zhao H, Xu X, Han L et al.. Development and evaluation of immunoglobulin-binding-proteins based ELISA for serological diagnosis of foot-and-mouth disease virus in domestic animals. International journal of biological macromolecules 2026. link 19 Gaffar S, Zulfa RS, Adikoesoemo F, Tazkia S, Novitriani K, Permana D et al.. Response surface methodology for optimization of scFv-BAD anti-E2 CHIKV expression in Escherichia coli Origami B (DE3) for the detection of Chikungunya virus. Preparative biochemistry & biotechnology 2026. link 20 Rout M, Pandey LK, Prusty BR, Mohapatra JK, Singh RP. Indirect ELISA diagnostic based on recombinant 3AB3 nonstructural protein of foot-and-mouth disease virus for use in porcine serology. Journal of immunological methods 2025. link 21 Zhang Y, Yao Y, Yan H, Zhang S, Xiao Y, Wang Y et al.. A Virus-Like Particle-Based Solid-Phase Competition Enzyme-Linked Immunosorbent Assay for Antibody Detection of Foot-and-Mouth Disease Virus Serotype O. Monoclonal antibodies in immunodiagnosis and immunotherapy 2020. link 22 Zhang Y, Yan H, Yao Y, Zhang S, Xiao Y, Xu X et al.. Development and validation of a solid-phase competition ELISA based on virus-like particles of foot-and-mouth disease virus serotype A for antibody detection. Archives of virology 2020. link 23 Wernike K, Beer M. Re-circulation of Schmallenberg virus, Germany, 2019. Transboundary and emerging diseases 2020. link 24 Ran X, Yang Z, Bai M, Zhang Y, Wen X, Guo H et al.. Development and validation of a competitive ELISA based on bacterium-original virus-like particles of serotype O foot-and-mouth disease virus for detecting serum antibodies. Applied microbiology and biotechnology 2019. link 25 Wang HM, Zhao GM, Hou PL, Yu L, He CQ, He HB. Rapid detection of foot-and-mouth disease virus using reverse transcription recombinase polymerase amplification combined with a lateral flow dipstick. Journal of virological methods 2018. link 26 Ali I, Dasti JI. Chikungunya virus; an emerging arbovirus in Pakistan. JPMA. The Journal of the Pakistan Medical Association 2018. link 27 Borah B, Deka P, Sharma K, Baro S, Hazarika AK, Das C et al.. Isolation, identification and retrospective study of foot-and-mouth disease virus from affected Mithun (Bos frontalis) in north-eastern India. Transboundary and emerging diseases 2018. link 28 Wu J, Zhao C, Liu Q, Huang W, Wang Y. Development and application of a bioluminescent imaging mouse model for Chikungunya virus based on pseudovirus system. Vaccine 2017. link 29 Wernike K, Beer M, Hoffmann B. Schmallenberg Virus Infection Diagnosis: Results of a German Proficiency Trial. Transboundary and emerging diseases 2017. link 30 Xu QY, Sun EC, Feng YF, Li JP, Lv S, Zhang Q et al.. Development of a novel protein chip for the detection of bluetongue virus in China. Journal of virological methods 2016. link 31 Maan NS, Maan S, Belaganahalli M, Pullinger G, Montes AJ, Gasparini MR et al.. A quantitative real-time reverse transcription PCR (qRT-PCR) assay to detect genome segment 9 of all 26 bluetongue virus serotypes. Journal of virological methods 2015. link 32 Mahajan S, Mohapatra JK, Pandey LK, Sharma GK, Pattnaik B. Indirect ELISA using recombinant nonstructural protein 3D to detect foot and mouth disease virus infection associated antibodies. Biologicals : journal of the International Association of Biological Standardization 2015. link 33 Capps B, Lederman Z. One Health and paradigms of public biobanking. Journal of medical ethics 2015. link 34 Rana J, Rajasekharan S, Gulati S, Dudha N, Gupta A, Chaudhary VK et al.. Network mapping among the functional domains of Chikungunya virus nonstructural proteins. Proteins 2014. link 35 Balmer S, Vögtlin A, Thür B, Büchi M, Abril C, Houmard M et al.. Serosurveillance of Schmallenberg virus in Switzerland using bulk tank milk samples. Preventive veterinary medicine 2014. link 36 Dutta SK, Pal T, Saha B, Mandal S, Tripathi A. Copy number variation of Chikungunya ECSA virus with disease symptoms among Indian patients. Journal of medical virology 2014. link 37 Garigliany MM, Desmecht D, Bayrou C, Peeters D. No serologic evidence for emerging Schmallenberg virus infection in dogs (Canis domesticus). Vector borne and zoonotic diseases (Larchmont, N.Y.) 2013. link 38 Mahajan S, Mohapatra JK, Pandey LK, Sharma GK, Pattnaik B. Truncated recombinant non-structural protein 2C-based indirect ELISA for FMD sero-surveillance. Journal of virological methods 2013. link 39 Azkur AK, Albayrak H, Risvanli A, Pestil Z, Ozan E, Yılmaz O et al.. Antibodies to Schmallenberg virus in domestic livestock in Turkey. Tropical animal health and production 2013. link 40 Fasina FO, Connell DR, Talabi OA, Lazarus DD, Adeleke GA, Olusanya TP et al.. Foot-and-mouth disease virus strains and examination of exposure factors associated with seropositivity of cattle herds in Nigeria during 2007-2009. Preventive veterinary medicine 2013. link 41 Ayelet G, Gelaye E, Negussie H, Asmare K. Study on the epidemiology of foot and mouth disease in Ethiopia. Revue scientifique et technique (International Office of Epizootics) 2012. link 42 Jaworski JP, Compaired D, Trotta M, Perez M, Trono K, Fondevila N. Validation of an r3AB1-FMDV-NSP ELISA to distinguish between cattle infected and vaccinated with foot-and-mouth disease virus. Journal of virological methods 2011. link 43 Negusssie H, Kyule MN, Yami M, Ayelet G, Jenberie S. Outbreak investigations and genetic characterization of foot-and-mouth disease virus in Ethiopia in 2008/2009. Tropical animal health and production 2011. link 44 Ranabijuli S, Mohapatra JK, Pandey LK, Rout M, Sanyal A, Dash BB et al.. Serological evidence of foot-and-mouth disease virus infection in randomly surveyed goat population of Orissa, India. Transboundary and emerging diseases 2010. link 45 Megersa B, Beyene B, Abunna F, Regassa A, Amenu K, Rufael T. Risk factors for foot and mouth disease seroprevalence in indigenous cattle in Southern Ethiopia: the effect of production system. Tropical animal health and production 2009. link 46 Mohapatra JK, Sanyal A, Hemadri D, Tosh C, Palani G, Rasool TJ et al.. Development and comparison of genome detection assays for the diagnosis of foot-and-mouth disease suspected clinical samples. Journal of virological methods 2006. link 47 Armstrong PM, Andreadis TG, Anderson JF, Main AJ. Isolations of Potosi virus from mosquitoes (Diptera: Culicidae) collected in Connecticut. Journal of medical entomology 2005. link 48 Wang CY, Chang TY, Walfield AM, Ye J, Shen M, Zhang ML et al.. Synthetic peptide-based vaccine and diagnostic system for effective control of FMD. Biologicals : journal of the International Association of Biological Standardization 2001. link 49 Meloen RH, Briaire J. A study of the cross-reacting antigens on the intact foot-and-mouth disease virus and its 12S Subunits with antisera against the structural proteins. The Journal of general virology 1980. link